Association of rheumatoid factor with complement activation in rheumatoid arthritis and other diseases. 1983

P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan

Rheumatoid factor (RF) is a complement activating autoantibody. In rheumatoid arthritis (RA) the rate of catabolism of complement is closely related to the titre of RF. Therefore, we have examined whether these relationships are unique to RA or will be found in non-RA disorders in which RF may be found in the circulation. We studied patients with subacute bacterial endocarditis, leprosy, tuberculosis, and a variety of other rheumatic and vasculitic disorders. We found that in all the disorders examined the RF had a complement activating potential which was equivalent to that of the RF of RA patients. Furthermore in vivo activation of complement, as exhibited by the appearance of C3 degradation products, was significantly related to higher titres of haemolytically active RF in non-RA as well as the RA group. In these respects, therefore, the RF in RA and non-RA patients is indistinguishable. A possible survival value for RF is discussed.

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004698 Endocarditis, Subacute Bacterial ENDOCARDIUM infection that is usually caused by STREPTOCOCCUS. Subacute infective endocarditis evolves over weeks and months with modest toxicity and rare metastatic infection. Endocarditis Lenta,Bacterial Endocarditides, Subacute,Bacterial Endocarditis, Subacute,Endocarditides, Subacute Bacterial,Subacute Bacterial Endocarditides,Subacute Bacterial Endocarditis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
June 1986, Disease markers,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
August 2017, Journal of immunology (Baltimore, Md. : 1950),
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
August 1983, Lancet (London, England),
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
April 1988, Annals of the rheumatic diseases,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
January 1989, Monographs in allergy,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
March 1974, Postepy higieny i medycyny doswiadczalnej,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
August 1986, British journal of rheumatology,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
December 1981, The Journal of clinical investigation,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
June 1982, Clinical and experimental immunology,
P A Reyes, and J G Maluf, and J G Curd, and J H Vaughan
February 1986, The Journal of rheumatology,
Copied contents to your clipboard!